STD Testing for LGBTQ+ People: Getting the Right Tests, from the Right Providers

LGBTQ+ individuals face higher rates of certain STDs than the general population, and the reason is not behaviour — it is structural. Gaps in provider training, screening protocols designed for heterosexual cisgender patients, and the persistent underrepresentation of LGBTQ+ people in clinical research all contribute to missed diagnoses and suboptimal care. Understanding these gaps is the first step to working around them.

Quick answer: MSM (men who have sex with men) should test for HIV, gonorrhea, chlamydia, and syphilis every 3–6 months regardless of symptoms. Transgender individuals should receive testing based on their anatomy, not their gender marker. LGBTQ+-affirming testing with no judgment and appropriate multi-site panels is available at clinics in San Francisco, New York City, Chicago, Washington DC, and Los Angeles.

STD Risk Patterns in LGBTQ+ Populations

The elevated STD risk in certain LGBTQ+ subgroups reflects specific biological and structural factors — not generalizable to all LGBTQ+ people. The key distinctions:

Gay and bisexual men, MSM: Anal sex carries higher per-exposure transmission rates for HIV, gonorrhea, chlamydia, and syphilis than vaginal sex. Rectal mucosa is more susceptible to infection than vaginal tissue. A standard urine-only STD test misses rectal and pharyngeal infections entirely, which are common and often asymptomatic in this population. The CDC recommends MSM with multiple or anonymous partners test every 3 months.

Women who have sex with women (WSW): STD rates are lower in WSW than in heterosexual women or MSM as a group, but not absent. Bacterial vaginosis and trichomoniasis transmit between female partners. HPV, herpes, and syphilis can transmit through skin-to-skin contact and shared sex toys. The assumption that WSW don't need STD screening is clinically incorrect.

Transgender individuals: Screening should be based on anatomy, not gender identity or gender marker. A transgender woman who has not had genital surgery has the same prostate and urethral anatomy as a cisgender man. A transgender man who has not had genital surgery should receive cervical screening per standard guidelines. Many standard STD panels are designed around binary male/female assumptions and will miss relevant sites if anatomy is not discussed explicitly with the provider.

Bisexual individuals: Have higher rates of STDs than either exclusively heterosexual or exclusively homosexual populations in several studies, which research attributes to lower access to sexual health services and higher rates of partner change in some sub-groups.

Getting the Right Tests: Multi-Site Screening

The single most common failure in STD testing for LGBTQ+ patients is anatomical mismatch — testing only the sites included in a standard panel that doesn't reflect actual exposure history.

Rectal gonorrhea and chlamydia are extremely common in MSM and are almost universally asymptomatic. They are missed entirely by urine tests. Pharyngeal gonorrhea is common in people who have oral sex (any gender) and is missed without a throat swab. Neither of these is in a standard clinical panel unless you ask.

When booking or attending any STD test, be explicit with the provider about the types of sex you have had. Say: "I've had receptive anal sex — I need a rectal swab." "I've had oral sex — I need a throat swab." Providers at dedicated sexual health clinics are trained to do this without judgment. Providers at general GP practices are variable.

HIV and PrEP

HIV disproportionately affects MSM and transgender women. The CDC recommends HIV testing at least annually for all sexually active LGBTQ+ people, and every 3 months for MSM with multiple partners. The 4th-generation antigen/antibody HIV test is accurate from 18–45 days after exposure.

PrEP (pre-exposure prophylaxis) — a daily oral medication or bi-monthly injection that prevents HIV acquisition — is highly effective and underused. It requires a prescription and regular monitoring. Any doctor can prescribe it; you don't need to see a specialist. Telehealth PrEP prescribing has expanded access significantly. If you're an MSM with multiple partners or a transgender woman who is sexually active, the conversation about PrEP is worth having at your next appointment.

Affirming Care: What to Look For

An affirming provider uses your correct name and pronouns without being asked. They ask about the types of sex you have, not your relationship structure or sexual orientation label. They offer multi-site testing based on your anatomy and behaviour. They don't make assumptions about your risk based on your identity. They're matter-of-fact about sexual health discussions.

Red flags: a provider who seems surprised by your sexual history, who doesn't know that rectal swabs are necessary for anal sex, or who uses your legal name/old pronouns after being corrected. These are signals to find a different provider for this type of care.

In cities with significant LGBTQ+ populations, dedicated sexual health clinics offer the most consistent affirming care. In areas without these, Planned Parenthood and Federally Qualified Health Centers (FQHCs) are generally better trained than general practices.

When to Seek Urgent Care

• Possible HIV exposure in the last 72 hours: go to an ER for PEP immediately — the window closes at 72 hours and cannot be extended.

• Rectal pain, discharge, or bleeding: same-day evaluation — possible rectal gonorrhea or proctitis.

• Painful sores or ulcers on any mucous membrane: same-day evaluation, not watchful waiting.

• Flu-like illness with rash 2–4 weeks after possible HIV exposure: this pattern suggests acute HIV — test and discuss PEP/treatment urgently.

Frequently Asked Questions

How often should MSM get tested?

At minimum annually, but every 3–6 months if you have multiple or anonymous partners. The CDC recommends 3-monthly HIV testing for MSM with higher-risk exposure patterns. At each test, ensure you're being tested at all relevant anatomical sites — urine, throat swab, and rectal swab — not just urine.

Do lesbians need STD testing?

Yes. STD transmission between women is less studied than in other groups but is documented for bacterial vaginosis, trichomoniasis, herpes, HPV, and syphilis. Annual testing for anyone sexually active is appropriate regardless of partner gender. Don't assume a provider will offer appropriate screening — be explicit about your sexual history.

How should transgender patients approach STD screening?

Ask for screening based on your anatomy rather than your gender identity. If you have a cervix, cervical/vaginal swabs and Pap tests apply. If you have a prostate, urethral testing applies. If you have receptive anal sex, rectal swabs apply. If you've had genital surgery, discuss with your provider which tests are anatomically relevant. Hormone therapy does not affect STD risk directly but may affect some aspects of anatomy and symptom presentation.

Can I get PrEP if I'm LGBTQ+ but not specifically MSM?

Yes. PrEP is indicated for anyone at substantial risk of HIV, regardless of sexual orientation or gender identity. This includes transgender women, transgender men who have sex with men, and anyone with HIV-positive partners who has ongoing sexual contact. Telehealth services have expanded access significantly for people in areas without affirming providers.

What if I've had a negative experience with a provider about my sexual health?

Document it if possible, consider reporting to the clinic's patient experience team, and find a different provider. Persistent bias from providers is a real problem and a legitimate reason to change clinics. Dedicated LGBTQ+ health centres, Planned Parenthood, and FQHCs tend to be more consistent in affirming practice than general medical settings.

Related: STD Testing: What You Need to Know · Understanding HIV · HIV Prevention and PrEP · How to Find Affordable STD Testing · Find a clinic near you →